Back To Search Results

Axonotmesis

Editor: Mustafa Nadi Updated: 6/12/2026 7:04:02 PM

Introduction

Peripheral nerve injuries (PNIs) are a relatively uncommon but potentially devastating health concern.[1] These injuries can occur during common procedures such as spine, foot, and ankle surgeries and arthroplasty, and often lead to litigation.[2][3] PNI may be traumatic or nontraumatic in nature and can often be iatrogenic. Early identification of injury is of paramount importance because prompt intervention is associated with the best neurological outcomes.  

Axonotmesis is a term that describes a range of PNI injuries more severe than a minor insult resulting in neurapraxia but less severe than nerve transection (neurotmesis). Ultimately, these terms describe the various grades of nerve trunk involvement based on an underlying molecular process. However, the descriptive terms used to categorize the degree of nerve damage allow the clinician to determine the mechanism of injury and formulate a therapeutic strategy that sets appropriate expectations for functional outcomes.

Familiarity with the basic anatomy of peripheral nerves is essential for understanding each grade of nerve injury. From the most superficial to the very deepest structures, the peripheral nerve contains epineurium (epifascicular epineurium intervening between fascicles), perineurium covering individual fascicles, and endoneurium that envelops axons, wrapped by a myelin sheath and Schwann cells. Seddon first classified nerve injuries into neuropraxia, axonotmesis, and neurotmesis. Sunderland later elaborated on the classification based on histological findings:

  • Grade I: Neurapraxia, wherein only focal segmental demyelination is present; this most often results from entrapment neuropathies or pressure palsies. 
  • Grade II: The axons are damaged, but all the protective perineural sheaths are intact. 
  • Grade III: Damage involves the axons and the endoneurium.  
  • Grade IV: Damage involves the axons, endoneurium, and the perineurium; this occurs most often following crush and stretch injuries.
  • Grade V: Neurotmesis, wherein even the epineurium is disrupted following massive trauma, sharp injuries, traction, or avulsion injuries.    
  • Grade VI: This includes multifocal and mixed patterns of injury within the same nerve (most common subtype).[4][5][6][7][8]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

PNIs may be broadly categorized by the status of the adjacent integuments. Closed injuries involve the nerve trunk without injuring the integument, while open injuries involve damage to both the nerve trunk and the adjacent integument. Open injuries may result from clean, sharp wounds or ragged, contused wounds.

An example of a clean, sharp injury is the transection of a nerve using a scalpel. A ragged, contusion injury may result from a projectile directly impacting the nerve. Ragged injuries lead to an increased inflammatory response, disruption of nerve fibers, fiber displacement, and potential foreign-body contamination.[9]  

Closed injuries are the result of nerve strain or contusion and may result from joint dislocation and crush injuries. Missile injuries are considered a subset of closed PNI, with features of concussive, thermal, and transection forces.[9] In general, neurapraxia follows compression or entrapment; axonotmesis is commonly the result of crush and stretch injuries; and neurotmesis occurs after sharp, traction, avulsion, or toxic damage to a nerve.[5] Common traumatic injuries with affected nerves include the following:

  • Seat belt: The upper trunk of the brachial plexus
  • Stab wound to the posterior triangle of the neck: Spinal accessory nerve
  • Shoulder dislocation: Axillary nerve
  • Humerus fracture: Radial nerve
  • Elbow dislocation: Median nerve
  • Pelvic fracture/hip dislocation: Sciatic nerve
  • Knee dislocation/fibular fracture: Peroneal nerve [9]

Nontraumatic focal nerve injuries are less common in the population. Compression can be interrupted by repositioning unaffected individuals. Spontaneous bleeding, vascular injury, and the mass effect or invasion of solid tumors can cause nerve injury. Examples of iatrogenic nonsurgical injuries include:

  • Nerve compression from an adjacent hematoma
  • Compression from improper positioning during a surgical procedure  
  • Neural tension or fibrosis from irradiation
  • Tension or compression from a tourniquet
  • Direct needle injury
  • Dressing- or device-related injury.

Iatrogenic surgical injuries may result from high tension, compression, and transection of the involved nerve. Procedures identified as carrying an increased risk of iatrogenic injury include varicose vein procedures, inguinal hernia repair, Baker cyst removal, carpal tunnel release, posterior cervical triangle biopsy, arthrodesis, osteotomy, and osteosynthesis. The spinal accessory nerve, injured during posterior triangle neck lymph node biopsy, and the median nerve, injured during carpal tunnel release, are among the nerves most likely to sustain iatrogenic injury.[10]

Epidemiology

The incidence of PNI following extremity trauma has been reported to be between 1.64% and 3.4%.[1] The most commonly injured upper extremity nerves are the radial nerve, followed by the ulnar nerve, and then the median nerve. The lower extremity nerves most likely to be injured are the sciatic, followed by the peroneal, and then the tibial and femoral nerves. Truncal nerves that can be injured are the ilioinguinal, genitofemoral, and spinal accessory nerves, in that order. PNI was most often associated with crush injuries.[9][10] 

Results from an analysis of a large database indicated an average annual incidence of upper extremity PNIs of 43.8 per 1 million individuals. The incidence decreased throughout the study, while the compound annual growth rate in cost was 9.6% between 2001 and 2013. Most patients were men, White, and admitted through the trauma and emergency department. The average age was 38.1 years, and the most common injury was a digital laceration. Most patients were discharged from the emergency department following their examination.[11]

Results from another database study indicated that lower-extremity PNIs had an annual average incidence of 13.3 cases per 1 million individuals. The mean age was 41.6 years, and most patients were men, with most admitted through the emergency department. The sciatic nerve was the most commonly injured nerve, and the most frequent injury was a lower extremity fracture. The compounded annual growth rate of the cost was 8.8% from 2001 to 2013.[12] Positioning nerve injuries are most likely to occur in individuals with extremes of body weight, in men, and in those with a history of nerve disease or comorbidities that would predispose them to a nerve injury.[13]

Pathophysiology

In states of axonotmesis and neurotmesis, stretching can lead to patchy ischemia and reduced blood flow within the vasa nervorum. As stretching progresses, intraneural connective tissue destruction, hemorrhage, and necrosis are likely to result. Disruption of trophic factors, degradation of cytoskeletal elements, increased intracellular calcium, and interruption of axonal transport will then progress sequentially.

In neurapraxia, compression or entrapment results in a temporary interruption of nerve conduction. Increased venous pressure and endoneurial edema result from prolonged compression, leading to Schwann cell fragmentation. Focal demyelination occurs, leading to the leakage of action potentials at the nodes of Ranvier, which most often causes slowing of conduction. However, if the internodal conduction time exceeds 5-600 μs, permanent conduction block may lead to muscle atrophy.[5] Axons are not involved during this process.[4]

In axonotmesis, the axons are disrupted.[5] Recovery in axonotmesis occurs either through collateral sprouting (20% to 30% of axons damaged) or regeneration (greater than 90% of axons damaged).[5][14] Within the first few hours, chromatolysis (breakdown of Nissl bodies) and swelling of the axotomized cell body and nucleus occur.[5]

Over the next few days, anterograde and retrograde Wallerian degeneration ensue. Wallerian degeneration is generally the fate of the distal end of the damaged nerve when over 90% of the axons are injured.[9] Proximal degradation is most often negligible, progressing only up to the nearest node of Ranvier.[9][15]

If the lesion is in close proximity to the cell body, neuronal death alone occurs. Within the distal axons, calcium influx activates calpains that cleave neurofilaments, causing axonal fragmentation.[7][16] The Schwann cell will shift to a phagocytic phenotype upon macrophage recruitment, clearing both axonal and myelin cellular debris (leaving only the basement membrane) within 3 to 6 weeks.[17]

Schwann cells then switch to a regenerative phenotype, releasing growth factors (ciliary and glial-derived neurotrophic factors).[13][15] The bands of Bungner are pivotal in guiding the emerging axonal sprouts into the distal stumps that cross the coaptation site and remain viable for up to 24 months after injury.[5][7][8][17] The sprouting, mediated by actin and guided by lamellipodia and filopodia, cytoplasmic extensions, occurs at a rate of 1 to 3 mm/day.[7][8][18] 

Regeneration of the myelin sheath takes 3 months.[19] Fibrosis and gap, however, impede this healing process, leading to the formation of a neuroma in continuity.[15] Neuroma in continuity results in persistent neuropathic pain.

Regarding the end organs, the remaining motor units in the muscles may initially show hypertrophy. A pruning process later sets in as axons diminish due to inadequate neurotrophic factors.[14] Preganglionic avulsion injuries with the discontinuity of the spinal roots to the central cord lack regenerative neurons, unlike postganglionic injuries that occur distal to the proximal stump.[9]

History and Physical

The diagnosis and treatment strategies for acute nerve injury are determined clinically. For that reason, obtaining a thorough history and physical examination is essential for providing quality patient care.[20] A complete trauma evaluation with a primary survey is indicated in most cases of traumatic PNI. Once the patient is stabilized and the critical aspects of patient care have been addressed, a secondary survey may proceed.

In both traumatic and atraumatic presentations, a complete neurologic examination is warranted. The clinician should test individual muscle strength, myotome performance, and dermatomes, and solicit the patient's subjective concerns regarding the examination. Clinicians should seek an associated trauma or disease state that can explain observed sensory, motor, and autonomic deficits noted on the examination.

In atraumatic presentations, attention should be directed to the patient's medications, oncologic risk, coagulopathy, mobility, and substance use. Electrophysiologic testing and advanced imaging can aid in diagnosis.[20] A baseline assessment is integral for meaningful surveillance because patient abilities may change over time.

In axonotmesis, large myelinated A-α nerve fibers mediating fast pain, temperature, light touch, and motor functions are most often affected. Smaller unmyelinated fibers, which modulate vasomotor and sudomotor autonomic function and slow pain C fiber conduction, are mostly spared. Wallerian degeneration leads to a positive Tinel sign. Following regeneration, resolution of autonomic dysfunction usually precedes motor and sensory recovery. Nonprogression of the Tinel sign, allodynia, and the presence of vasomotor and sudomotor signs most often suggest nerve transection.[19]

Evaluation

Evaluation begins with a comprehensive history and physical examination, including careful attention to autonomic function, myotomes, and dermatomes. If the PNI is open, the wound may be explored immediately to determine the extent of damage and provide surgical intervention if indicated. For cases with a possibility of spontaneous recovery (lower-grade axonotmesis and neurapraxia), patients should be monitored weekly to assess functional recovery. If spontaneous recovery does not occur within a few months, a surgical procedure is warranted.

Electrophysiologic Findings

Electrophysiological findings are time-dependent. The axons remain excitable up to 7 to 11 days after injury, so sensory nerve action potential and compound muscle action potential (CMAP) results will be normal during this period.[9] Conduction may also be normal until complete Wallerian degeneration sets in.[15] Thereafter, a conduction block with preserved distal electromyographic responses is suggestive of neuropraxia.[21] Nerve conduction block occurs at an amplitude reduction of 50% to 75%.[15][21] 

CMAP is the summation of the response of the motor endplate potentials. Electrode stimulation during motor conduction studies reflects the volume of intact axons. In Wallerian degeneration, CMAP values decrease significantly approximately 10 days after injury.

Within 2 to 3 weeks, fibrillations and positive sharp waves appear in the needle electromyography. In the first weeks to months, reinnervation via sprouting and collaterals shows polyphasic, unstable motor unit action potentials and satellite potentials (thin, unmyelinated sprouts with immature neuromuscular junctions). The slower-healing phase of axonal regrowth eventually sets in, resulting in larger-amplitude, longer-duration potentials.

Conversely, in neurotmesis, lesion patterns show no motor unit action potential recruitment. Intraoperative electrophysiological studies are also valuable adjuncts to surgical planning, such as in the repair of a neuroma in continuity.[5] Bridge grounding is recommended during intraoperative neuromonitoring to limit the loop effect from the lifting method.[22]

Imaging studies

Ultrasonography may show altered echogenicity, edema, a distorted fascicular (honeycomb) pattern, a neuroma, and muscular atrophy (compared to healthy counterparts).[23][24][25][26][27][28][29][30] Ultrasonography is cost-effective, fast, easily reproducible, and allows real-time assessment. However, ultrasonography is operator-dependent, limited to superficial nerves, and does not provide physiological data.

T2 magnetic resonance images reveal a loss of fascicular pattern and edema in axonotmesis. Conversely, neuroma, muscle atrophy, and fatty replacement are observed in neurotmesis. Although high-resolution magnetic resonance neurography has been used to assess nerve continuity, 50% of transections paradoxically may show no gaps. The average dispersion coefficient in diffusion tensor imaging and tractography also helps dichotomize injury and predict recovery.[31][32][33] Cost, claustrophobia, pertinent contraindications, and availability are limiting factors.[17]

Treatment / Management

In cases of neurapraxia, closed injuries, and lower-grade axonotmesis, a baseline assessment with serial examinations is warranted to observe for spontaneous regeneration. If functional restoration does not occur within 3 months, surgical intervention should be considered.[9] Clinical photography and detailed descriptions of the injury are of paramount importance in treatment.[19] Surgical intervention is based on the principle of providing treatment before irreversible damage occurs.[34] 

The time aspect plays a paramount role in the management of PNI. Open injuries with clean, sharp lacerations are treated within 3 hours of injury. Both nerve segments will continue to retract after the initial injury; thus, the nerve should be repaired before retraction precludes primary repair due to consequent ischemia-inducing tension. Direct repair may be between epineural substance, perineural substance, or group fascicle repair at a time when nerves are tension-free. Immunohistochemistry and intraoperative electrophysiology will aid in coaptation of sensory axons with sensory fibers and motor axons with motor fibers, which is important for improved recovery.

Open injuries with dirty, blunt lacerations are delayed to allow better demarcation of the injury and to avoid infection. Ragged, contusion injuries fail to demonstrate the extent of nerve damage until approximately 2 to 3 weeks following the injury. Given this presentation, primary repair is not indicated.

Instead, the nerve endings are anchored to the adjacent muscle or fascia to mitigate retraction. Once reassessed weeks following the initial injury, devitalized tissue is excised, followed by a tension-free repair. Should the gap between the proximal and distal nerve segments be significant, an intervening nerve graft is indicated.

Likewise, regardless of the gap size, if the nerve appears under tension during repair, an intervening nerve graft may be indicated.[15] Open injuries with nerve discontinuity (but epineurium intact) and all closed injuries are initially treated conservatively, and nerve function evaluation is performed at 3 weeks.[17] If clinical or electrical recovery is not evident even at 3 months, surgical intervention is required.[17](B2)

Surgical Management in Peripheral Nerve Injuries

  • Neurolysis: When neurophysiologic monitoring demonstrates an intact nerve segment distal to the damaged site
  • Nerve repair: Nerve repair consists of epineurial (most important in tension-free repair), perineurial repair (high risk of fibrosis, fascicular discontinuity), and group fascicular repair.[35][36] Either end-to-end or end-to-side neurorrhaphy can be performed. Minimal use of nonabsorbable monofilament sutures is recommended. Fibrin sealant can also be used to reduce the need for sutures and mitigate granuloma and neuroma formation. Tension and misalignment need to be avoided.
  • Nerve reconstruction: Nerve reconstruction is performed via the use of nerve grafts or cables and conduits (silicon tube, spider silk). Autologous sensory nerve grafting is the gold-standard option. However, limited supply, donor-site morbidity, size mismatch, and the fact that only 40% to 50% show notable improvement due to fascicular mismatch are inherent limitations. Nonneural grafts, such as blood vessels and freeze-thawed skeletal muscle, can also be used.[7][15] Allograft use requires concurrent immunosuppression.[15][36]
  • Nerve transfer and neurotization: For delayed cases, nerve transfer should be performed within a critical 6- to 9-month window.[15][17][19][37]
  • (B2)

Surgical dictum during nerve repair

  • Viable nerve ends
  • Proper fascicular alignment to prevent pruning-induced preferential motor reinnervation and denervation-induced atrophy
  • Tension-free coaptation
  • Microsurgical repair under magnification [7][20]
  • (A1)

Adjuvant Management Modalities

  • Epigenetics and gene therapy: Examples include the delivery of ciliary neurotrophic factor using an adenoviral-associated vector.[16] However, ethical, biosafety, and mutagenesis concerns remain.[38]
  • Cell-based therapy: Stem cell therapy, secretome–Schwann cell therapy, cell-seeded scaffolds, aided recently by 3-dimensional (3D) and 4D printed conduits, and nanomedicine.[17][36][39][40] Mesenchymal stem cells can differentiate into Schwann cells, secrete neurotrophic factors, exhibit self-renewal, migrate to sites of injury, prevent apoptosis, form the extracellular matrix, and enhance angiogenesis. Mesenchymal stem cells can be obtained from bone marrow, adipose tissue, dental pulp, amniotic fluid, and umbilical cord.[16]
  • Platelet-rich plasma (PRP): PRP promotes tissue regeneration by releasing bioactive growth factors that stimulate angiogenesis and connective tissue remodeling. Emerging evidence indicates that PRP exerts neuroregenerative and analgesic effects. Its therapeutic potential has been demonstrated in the repair of various nerves.[41]
  • Stimulation via electrical, ultrasonographic, magnetic, or laser photobiomodulation methods increases the number and diameter of regenerated axons.[7][16]
  • Pharmacotherapy includes corticosteroids (minimize scarring), androgens, erythropoietin (promotes myelin), 4-aminopyridine (facilitates calcium influx and synaptic transmission), L-carnitine, tacrolimus, melatonin, citicoline, gabapentin, and polyethylene glycol.[17] 
  • Restorative medicine: Niclosamide reprograms glial scarring and extracellular matrix stiffening. [42]
    • Phytochemicals [36]
  • Nutritional therapy includes polyunsaturated fatty acids, vitamin B6, vitamin B12, and vitamin C.
  • Physical therapy
  • (A1)

Some patients will experience disability and pain syndromes despite the best efforts of their care team. An interdisciplinary approach encompassing physical therapy, neurology, neurosurgery, plastic surgery, psychiatry, orthopedic surgery, and pain medicine is therefore essential to address the needs of these patients. Such needs may include prostheses, chronic pain therapy, and cosmetic solutions for muscle atrophy.

The full extent of services required for PNI is beyond the scope of this article. Significant gaps in knowledge and evidence remain.[17] Animal study models and lab-on-a-chip neural modeling might provide newer insights into the treatment of PNI.[43](B2)

Differential Diagnosis

PNIs are diagnosed through careful history-taking and a thorough neurologic examination, with the aid of electrophysiologic testing and imaging modalities such as ultrasonography and MRI. Other conditions in the differential diagnosis include those that interfere with sensory, autonomic, and motor responses. Without an identifiable event to explain focal PNI, the clinician must use additional tools to determine the etiology of the patient's deficits.

Muscular disease, central nervous system impairment, electrolyte abnormalities, vascular compromise, autoimmune disease, toxin exposure, and infectious causes should be considered in the differential diagnosis. Most notable considerations include neuropraxia and neurotmesis.[15] Please see StatPearls' companion reference, "Peripheral Nerve Injury," for further information.

Prognosis

The prognosis of axonotmesis depends on the patient's underlying condition and the nature of the nerve injury. In axonotmesis, though Wallerian degeneration occurs due to axonotomy, the intact perineural sheaths most often redirect growing axonal buds to the distal stumps, thereby ensuring good functional recovery. Paradoxically, in neurotmesis, the protective coats are also damaged, and scarring imprisons the axonal buds, leading to neuromas in continuity. Therefore, recovery without therapy is almost impossible.[16] The regeneration process slows down at the distal nerve end.[17] The recovery of conduction velocity is also limited to 60% to 90% of the preinjury level despite neural regeneration.

Injury characteristics primarily determine clinical outcomes. Secondary reconstruction after damage-control surgical interventions has not been demonstrated to negatively affect clinical outcomes.[44] Neural function also depends on effective communication between regenerated axons and the end organ.

Muscle architecture and motor endplates are considered viable for up to 1 year after injury. Merkel cells, Pacinian corpuscles, and Meissner corpuscles may persist for 2 to 3 years after denervation. Given that the damaged peripheral nerve grows at approximately 1 to 2 mm per day, clinicians should intervene within the first 3 to 6 months after PNI if there are no signs of spontaneous recovery. Communication with the end organ must be reestablished within a limited timeframe.[9][13][14] Therefore, early intervention for the damaged nerve is suggested before progressive scarring and atrophy of the end organ render the tissue nonviable.    

Prognostic factors for regaining nerve function include a patient's baseline health, the mechanism of injury, the degree of injury, the length of the nerve gap (in axonotmesis and neurotmesis), the type of injury, the nerves involved (the spinal accessory nerve is most robust), the location of injury along the nerve (distal injuries have a better prognosis), the presence of concomitant injuries, the timing to surgical intervention, the type of surgical procedure, and the patient's age.[5][9][10][13][14][15] Activated transcription factor 3, bridging integrator 2, Fc fragment of immunoglobulin G receptor IIb, and urocortin are critical biomarkers of nerve injury and play roles in neurotrophic signaling and neuronal recovery.[45]

Complications

Without an intact tubule to guide neuronal regeneration, aberrant nerve growth into a neuroma is possible. Any foreign body used for suturing, conduits, or grafts can elicit an immune response, leading to scarring, pain, and failure of nerve regeneration. Allografts are seldom used, but patients who receive them are at risk of immunosuppression-related complications.

Autografts may increase morbidity from injury to structures related to the extraction site. The maximal neural deficit will occur within days following the injury. Should improved nerve function relapse or progressively decline, other atraumatic etiologies should be investigated, such as pseudoaneurysm or hematoma formation.[9]

Postoperative and Rehabilitation Care

Assessment of Nerve Recovery

  • Clinical evaluation
  • Motor recovery: Walking track analysis and sciatic functional index 
  • Nociception: Withdrawal reflex latency
  • Facial nerve: Whisker test 
  • Histological assessment for the myelinated axons in animal models: Toluidine blue
  • Immunofluorescent staining and immunohistochemistry: Growth-associated protein 43 for laminin, a component of the extracellular matrix, within the newly formed axons
  • Neurophysiology studies
  • Functional neuroimaging such as diffusor tensor imaging [8][16][17]

Rehabilitation 

  • Following a nerve graft or transfer with no tension at the coaptation site:
    • Immobilization should be minimized for 3 to 10 days. However, following end-to-end repair, this period should be at least 3 weeks to minimize scar and collagen formation at the coaptation site.[37]
  • Contractures prevention
  • Prevention of muscle atrophy
  • Neuropathic pain management
  • Sensorimotor reeducation because of cortical remapping [17][37]

Deterrence and Patient Education

The prevalence of traumatic causes of PNI emphasizes the importance of patient safety education and the use of personal protective equipment. Additionally, patients should be encouraged to have a low threshold for seeking care if they develop abnormal sensory, motor, or autonomic responses. To decrease iatrogenic PNI, clinicians should be familiar with the local anatomy at the site where they may be placing a needle, an orthotic device, or a bandage, applying a tourniquet, positioning a patient, or performing a procedure.

Patients should provide informed consent before interventions that involve disclosure of the risk of unintended tissue damage, including nervous tissue injury. Clinicians should be conscientious and cautious when positioning patients and performing procedures. Detailed documentation regarding a nerve-preserving technique is highly recommended, though it is not completely protective against litigation.[13]

Patients should be educated about appropriate expectations for regaining function and that full recovery may not be attainable despite maximal medical care. In all cases of nerve injury, continued use and engagement of the affected end organ is crucial to maintain the plasticity of the sensorimotor and cortical neurons. Activity maximizes compensatory mechanisms, helps prevent contractures, and desensitizes patients to neuropathic pain.

Pearls and Other Issues

The Rule of 3s for Nerve Injury

  • Sharp, clean nerve injuries should be explored and repaired within 3 hours
  • Ragged, contusion injuries should have the ragged ends attached to a nearby anatomical structure immediately, then be repaired within 3 weeks
  • Closed injuries without evidence of neuronal recovery should be repaired within 3 months [9]

Early intervention is mandated if there is doubt, a delay in recovery, deterioration, debilitating pain, nonregression of the Tinel sign, or autonomic symptoms.[19] The RAMA principles (recognize, acknowledge, mitigate, and apologize) have been advocated in managing iatrogenic PNIs.[19]

Enhancing Healthcare Team Outcomes

The Walter Reed National Military Medical Center Peripheral Nerve Program was established to address PNIs and their associated complications. The team consists of mental health, rehabilitation, physical medicine, and pain clinicians; physical therapists; occupational therapists; neurologists; clinical neurophysiologists; neurosurgeons; and plastic and orthopedic hand surgeons. The purpose of this program is to maximize efficiency and eliminate fragmented care by providing a tumor board-like review of patient cases and a monthly comprehensive clinic during which clinicians from the aforementioned disciplines are available. This program has enabled the institution to serve a large volume of patients, maintain dynamic training programs, and produce PNI-related research.

The major concerns of this organization are undertreated patients and delays in PNI interventions. Delays are well-documented to result in worse functional outcomes for patients. Consequently, this program offers telemedicine to its patients, providing a direct route to PNI clinicians. Additionally, consolidating PNI resources facilitates faster responses to injuries and rapid communication among involved clinicians, thereby prioritizing patient safety and outcomes.[2]

References


[1]

Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury in extremity trauma. American journal of physical medicine & rehabilitation. 2008 May:87(5):381-5. doi: 10.1097/PHM.0b013e31815e6370. Epub     [PubMed PMID: 18334923]

Level 2 (mid-level) evidence

[2]

Wade SM, Nesti LJ, Cook GA, Bresner JS, Happel JP, Villahermosa AJ, Melendez-Munoz AM, Gomez YD, Reece DE, Miller ME, Souza JM. Managing Complex Peripheral Nerve Injuries Within the Military Health System: A Multidisciplinary Approach to Treatment, Education, and Research at Walter Reed National Military Medical Center. Military medicine. 2020 Jun 8:185(5-6):e825-e830. doi: 10.1093/milmed/usz415. Epub     [PubMed PMID: 31783405]


[3]

Cohen D, Backstein D. Nerve Injuries in Total Knee Arthroplasty. The Orthopedic clinics of North America. 2022 Apr:53(2):123-127. doi: 10.1016/j.ocl.2021.11.002. Epub 2022 Mar 5     [PubMed PMID: 35365256]


[4]

Sunderland S. The anatomy and physiology of nerve injury. Muscle & nerve. 1990 Sep:13(9):771-84     [PubMed PMID: 2233864]


[5]

Kamble N, Shukla D, Bhat D. Peripheral Nerve Injuries: Electrophysiology for the Neurosurgeon. Neurology India. 2019 Nov-Dec:67(6):1419-1422. doi: 10.4103/0028-3886.273626. Epub     [PubMed PMID: 31857526]


[6]

Mackinnon SE. Future Perspectives in the Management of Nerve Injuries. Journal of reconstructive microsurgery. 2018 Nov:34(9):672-674. doi: 10.1055/s-0038-1639353. Epub 2018 Apr 1     [PubMed PMID: 29605951]

Level 3 (low-level) evidence

[7]

M F G, M M, S H, Khan WS. Peripheral nerve injury: principles for repair and regeneration. The open orthopaedics journal. 2014:8():199-203. doi: 10.2174/1874325001408010199. Epub 2014 Jun 27     [PubMed PMID: 25067975]


[8]

Lopes B, Sousa P, Alvites R, Branquinho M, Sousa AC, Mendonça C, Atayde LM, Luís AL, Varejão ASP, Maurício AC. Peripheral Nerve Injury Treatments and Advances: One Health Perspective. International journal of molecular sciences. 2022 Jan 14:23(2):. doi: 10.3390/ijms23020918. Epub 2022 Jan 14     [PubMed PMID: 35055104]

Level 3 (low-level) evidence

[9]

Smith BW, Sakamuri S, Spain DA, Joseph JR, Yang LJ, Wilson TJ. An update on the management of adult traumatic nerve injuries-replacing old paradigms: A review. The journal of trauma and acute care surgery. 2019 Feb:86(2):299-306. doi: 10.1097/TA.0000000000002081. Epub     [PubMed PMID: 30278019]


[10]

Rasulić L, Savić A, Vitošević F, Samardžić M, Živković B, Mićović M, Baščarević V, Puzović V, Joksimović B, Novakovic N, Lepić M, Mandić-Rajčević S. Iatrogenic Peripheral Nerve Injuries-Surgical Treatment and Outcome: 10 Years' Experience. World neurosurgery. 2017 Jul:103():841-851.e6. doi: 10.1016/j.wneu.2017.04.099. Epub 2017 Apr 24     [PubMed PMID: 28450236]


[11]

Karsy M, Watkins R, Jensen MR, Guan J, Brock AA, Mahan MA. Trends and Cost Analysis of Upper Extremity Nerve Injury Using the National (Nationwide) Inpatient Sample. World neurosurgery. 2019 Mar:123():e488-e500. doi: 10.1016/j.wneu.2018.11.192. Epub 2018 Nov 28     [PubMed PMID: 30502477]


[12]

Foster CH, Karsy M, Jensen MR, Guan J, Eli I, Mahan MA. Trends and Cost-Analysis of Lower Extremity Nerve Injury Using the National Inpatient Sample. Neurosurgery. 2019 Aug 1:85(2):250-256. doi: 10.1093/neuros/nyy265. Epub     [PubMed PMID: 29889258]


[13]

Winfree CJ, Kline DG. Intraoperative positioning nerve injuries. Surgical neurology. 2005 Jan:63(1):5-18; discussion 18     [PubMed PMID: 15639509]


[14]

Menorca RM, Fussell TS, Elfar JC. Nerve physiology: mechanisms of injury and recovery. Hand clinics. 2013 Aug:29(3):317-30. doi: 10.1016/j.hcl.2013.04.002. Epub     [PubMed PMID: 23895713]

Level 3 (low-level) evidence

[15]

Bhandari PS. Management of peripheral nerve injury. Journal of clinical orthopaedics and trauma. 2019 Sep-Oct:10(5):862-866. doi: 10.1016/j.jcot.2019.08.003. Epub 2019 Aug 13     [PubMed PMID: 31528058]


[16]

Bateman EA, Pripotnev S, Larocerie-Salgado J, Ross DC, Miller TA. Assessment, management, and rehabilitation of traumatic peripheral nerve injuries for non-surgeons. Muscle & nerve. 2025 May:71(5):696-714. doi: 10.1002/mus.28185. Epub 2024 Jun 21     [PubMed PMID: 39030747]


[17]

Barrett JP, Downey MS, Hillstrom HJ. Retrospective analysis of neurapraxia and axonotmesis injuries of select peripheral nerves of the foot and ankle and their conservative and surgical treatment (external neurolysis and neurectomy). The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons. 1999 May-Jun:38(3):185-93     [PubMed PMID: 10384357]

Level 2 (mid-level) evidence

[18]

Girouard MP, Bueno M, Julian V, Drake S, Byrne AB, Fournier AE. The Molecular Interplay between Axon Degeneration and Regeneration. Developmental neurobiology. 2018 Oct:78(10):978-990. doi: 10.1002/dneu.22627. Epub 2018 Jul 18     [PubMed PMID: 30022605]


[19]

Bage T, Power DM. Iatrogenic peripheral nerve injury: a guide to management for the orthopaedic limb surgeon. EFORT open reviews. 2021 Aug:6(8):607-617. doi: 10.1302/2058-5241.6.200123. Epub 2021 Aug 10     [PubMed PMID: 34532069]


[20]

Harhaus L, Dengler NF, Schwerdtfeger K, Stolle A. Clinical Practice Guideline: The Treatment of Peripheral Nerve Injuries. Deutsches Arzteblatt international. 2024 Aug 9:121(16):534-538. doi: 10.3238/arztebl.m2024.0071. Epub     [PubMed PMID: 38831698]

Level 1 (high-level) evidence

[21]

Eder M, Schulte-Mattler W, Pöschl P. Neurographic course Of Wallerian degeneration after human peripheral nerve injury. Muscle & nerve. 2017 Aug:56(2):247-252. doi: 10.1002/mus.25489. Epub 2017 Feb 27     [PubMed PMID: 27875622]


[22]

Wu G, Belzberg A, Nance J, Gutierrez-Hernandez S, Ritzl EK, Ringkamp M. Solutions to the technical challenges embedded in the current methods for intraoperative peripheral nerve action potential recordings. Journal of neurosurgery. 2020 Sep 1:133(3):884-893. doi: 10.3171/2019.5.JNS19146. Epub 2019 Aug 16     [PubMed PMID: 31419790]


[23]

Pitman J, Fayad LM, Dabiri M, Ahlawat S. Classification of Peripheral Nerve Injury. Magnetic resonance imaging clinics of North America. 2025 Aug:33(3):427-436. doi: 10.1016/j.mric.2025.03.003. Epub 2025 May 16     [PubMed PMID: 40610156]


[24]

Samet JD. Ultrasound of peripheral nerve injury. Pediatric radiology. 2023 Jul:53(8):1539-1552. doi: 10.1007/s00247-023-05631-8. Epub 2023 Mar 14     [PubMed PMID: 36914838]


[25]

Goyal A, Wadgera N, Srivastava DN, Ansari MT, Dawar R. Imaging of traumatic peripheral nerve injuries. Journal of clinical orthopaedics and trauma. 2021 Oct:21():101510. doi: 10.1016/j.jcot.2021.101510. Epub 2021 Jul 19     [PubMed PMID: 34386344]


[26]

Mologne MS, Randall ZD, Olafsen NP, Brogan DM, Dy CJ. Correlation of Ultrasound and Electrodiagnostic Evaluation in Ballistic Peripheral Nerve Injuries. Plastic and reconstructive surgery. Global open. 2025 Jun:13(6):e6846. doi: 10.1097/GOX.0000000000006846. Epub 2025 Jun 5     [PubMed PMID: 40474927]


[27]

Dong Y, Alhaskawi A, Zhou H, Zou X, Liu Z, Ezzi SHA, Kota VG, Abdulla MHAH, Olga A, Abdalbary SA, Chi Y, Lu H. Imaging diagnosis in peripheral nerve injury. Frontiers in neurology. 2023:14():1250808. doi: 10.3389/fneur.2023.1250808. Epub 2023 Sep 14     [PubMed PMID: 37780718]


[28]

Symanski JS, Ross AB, Davis KW, Brunner MC, Lee KS. US for Traumatic Nerve Injury, Entrapment Neuropathy, and Imaging-guided Perineural Injection. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022 Sep-Oct:42(5):1546-1561. doi: 10.1148/rg.210152. Epub 2022 Jul 1     [PubMed PMID: 35776677]


[29]

Elkholy AR, Rezk EM, Shabaan N, Elkhouly RM, Shamhoot EA. The role of preoperative ultrasound in the management of peripheral nerve injuries. Clinical neurology and neurosurgery. 2024 Jan:236():108083. doi: 10.1016/j.clineuro.2023.108083. Epub 2023 Dec 13     [PubMed PMID: 38104445]


[30]

Nouh MR, Abdel-Naby HM, El Sakka T, El-Shafei M. Peripheral nerve ultrasound: a survival guide for the practicing radiologist with updates. The ultrasound journal. 2025 Mar 26:17(1):21. doi: 10.1186/s13089-024-00387-0. Epub 2025 Mar 26     [PubMed PMID: 40138059]


[31]

Liu L, Kang X, Yang X, Yang C, Wang G, Xia L, Yang J. Diffusion Tensor Imaging to Assess Injury Severity in Rabbits With Acute Spinal Cord Injury. NMR in biomedicine. 2026 Mar:39(3):e70245. doi: 10.1002/nbm.70245. Epub     [PubMed PMID: 41709471]


[32]

Kamagata K, Andica C, Uchida W, Takabayashi K, Saito Y, Lukies M, Hagiwara A, Fujita S, Akashi T, Wada A, Hori M, Kamiya K, Zalesky A, Aoki S. Advancements in Diffusion MRI Tractography for Neurosurgery. Investigative radiology. 2024 Jan 1:59(1):13-25. doi: 10.1097/RLI.0000000000001015. Epub 2023 Sep 14     [PubMed PMID: 37707839]


[33]

Farinas AF, Manzanera Esteve IV, Pollins AC, Cardwell NL, Does MD, Dortch RD, Thayer WP. Diffusion Tensor Tractrography Visualizes Partial Nerve Laceration Severity as Early as 1 Week After Surgical Repair in a Rat Model Ex Vivo. Military medicine. 2020 Jan 7:185(Suppl 1):35-41. doi: 10.1093/milmed/usz360. Epub     [PubMed PMID: 32074298]


[34]

Liu X, Duan X. Mechanisms and Treatments of Peripheral Nerve Injury. Annals of plastic surgery. 2023 Aug 1:91(2):313-318. doi: 10.1097/SAP.0000000000003480. Epub 2023 Mar 2     [PubMed PMID: 36880740]


[35]

Wu S, Shen W, Ge X, Ao F, Zheng Y, Wang Y, Jia X, Mao Y, Luo Y. Advances in Large Gap Peripheral Nerve Injury Repair and Regeneration with Bridging Nerve Guidance Conduits. Macromolecular bioscience. 2023 Oct:23(10):e2300078. doi: 10.1002/mabi.202300078. Epub 2023 Jun 14     [PubMed PMID: 37235853]

Level 3 (low-level) evidence

[36]

Hussain G, Wang J, Rasul A, Anwar H, Qasim M, Zafar S, Aziz N, Razzaq A, Hussain R, de Aguilar JG, Sun T. Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery. International journal of biological sciences. 2020:16(1):116-134. doi: 10.7150/ijbs.35653. Epub 2020 Jan 1     [PubMed PMID: 31892850]


[37]

Novak CB, von der Heyde RL. Evidence and techniques in rehabilitation following nerve injuries. Hand clinics. 2013 Aug:29(3):383-92. doi: 10.1016/j.hcl.2013.04.012. Epub 2013 Jun 12     [PubMed PMID: 23895718]


[38]

Modrak M, Talukder MAH, Gurgenashvili K, Noble M, Elfar JC. Peripheral nerve injury and myelination: Potential therapeutic strategies. Journal of neuroscience research. 2020 May:98(5):780-795. doi: 10.1002/jnr.24538. Epub 2019 Oct 13     [PubMed PMID: 31608497]


[39]

Yoo MC, Lee JH, Lee JM, Kim YJ, Yeo SG. Effects of human embryonic stem cell-derived Schwann cells for nerve regeneration after facial nerve injury. Cell transplantation. 2026 Jan-Dec:35():9636897261422301. doi: 10.1177/09636897261422301. Epub 2026 Feb 23     [PubMed PMID: 41725378]


[40]

Abbaszadeh ME, Ghahremanzadeh A, Alizadeh F, Maddahi B, Disnad SE, Ojaroodi AF, Mobayen G, Oskouei SA, Lahouty M, Fadaee M. Neural Stem Cells and Inflammation Modulation in Preclinical Spinal Cord Injury: A Systematic Review. Molecular neurobiology. 2026 Feb 17:63(1):448. doi: 10.1007/s12035-026-05752-9. Epub 2026 Feb 17     [PubMed PMID: 41703313]

Level 1 (high-level) evidence

[41]

Wang S, Liu Z, Wang J, Cheng L, Hu J, Tang J. Platelet-rich plasma (PRP) in nerve repair. Regenerative therapy. 2024 Dec:27():244-250. doi: 10.1016/j.reth.2024.03.017. Epub 2024 Apr 4     [PubMed PMID: 38586873]


[42]

Sanoj Rejinold N, Jin GW, Choy JH. Nanoengineered Niclosamide as a Microenvironment Modulator for Spinal Cord Regeneration: A Hypothetical Roadmap Toward Brain/Head Transplant Feasibility. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. 2026 Jan-Feb:18(1):e70054. doi: 10.1002/wnan.70054. Epub     [PubMed PMID: 41725352]

Level 2 (mid-level) evidence

[43]

Zhang H, Rong G, Bian S, Sawan M. Lab-on-Chip Microsystems for Ex Vivo Network of Neurons Studies: A Review. Frontiers in bioengineering and biotechnology. 2022:10():841389. doi: 10.3389/fbioe.2022.841389. Epub 2022 Feb 16     [PubMed PMID: 35252149]


[44]

Wang E, Inaba K, Byerly S, Escamilla D, Cho J, Carey J, Stevanovic M, Ghiassi A, Demetriades D. Optimal timing for repair of peripheral nerve injuries. The journal of trauma and acute care surgery. 2017 Nov:83(5):875-881. doi: 10.1097/TA.0000000000001570. Epub     [PubMed PMID: 28590354]


[45]

Cao S, Yu C, Wang N, Xu J, Xu W. Screening Biomarkers for Nerve Injury Using Weighted Gene Co-Expression Network Analysis and Machine Learning. Brain and behavior. 2026 Feb:16(2):e71279. doi: 10.1002/brb3.71279. Epub     [PubMed PMID: 41733593]